| PROTALIX BIOTHERAPEUTICS INC. |
| USA |
| Gesundheit |
| US74365A3095 / A2PWSL |
| PBDA (Frankfurt) |
| FRA:PBDA, ETR:PBDA, PBDA:GR |
| - |
| http://protalix.com/ |
|
Protalix Biotherapeutics Inc. is a biopharmaceutical company focused on developing and manufacturing therapeutic proteins using its proprietary plant cell-based expression system. This innovative platform allows for the production of recombinant prot..
>Volltext.. |
| 172.93 Mio. EUR |
| 135.49 Mio. EUR |
| 66.1 Mio. EUR |
| 18.45 Mio. EUR |
| 13.27 Mio. EUR |
| 0.17 EUR |
| 7.34 Mio. EUR |
| 36.1 Mio. EUR |
| 13.06 Mio. EUR |
| 1.89 |
| 19.67% |
| 267.36% |
| - |
| - |
| - |
| - |
| PROTALIX |
| 12.08.26 |
|